BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 28110202)

  • 1. Hyperpolarized MRI, functional MRI, MR spectroscopy and CEST to provide metabolic information in vivo.
    van Zijl PCM; Brindle K; Lu H; Barker PB; Edden R; Yadav N; Knutsson L
    Curr Opin Chem Biol; 2021 Aug; 63():209-218. PubMed ID: 34298353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate tumour visualisation with PET: is image fusion with MRI the answer?
    Mehawed G; Murray R; Rukin NJ; Roberts MJ
    BJU Int; 2024 Apr; 133 Suppl 4():4-6. PubMed ID: 38477216
    [No Abstract]   [Full Text] [Related]  

  • 3. Emerging methods for prostate cancer imaging: evaluating cancer structure and metabolic alterations more clearly.
    Retter A; Gong F; Syer T; Singh S; Adeleke S; Punwani S
    Mol Oncol; 2021 Oct; 15(10):2565-2579. PubMed ID: 34328279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current opportunities and challenges of magnetic resonance spectroscopy, positron emission tomography, and mass spectrometry imaging for mapping cancer metabolism in vivo.
    Lin G; Chung YL
    Biomed Res Int; 2014; 2014():625095. PubMed ID: 24724090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testicular metastasis of prostate origin diagnosed by PET/MR with
    Garcia JR; Compte A; Bassa P; Soler M; Buxeda M; Riera E
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021 Aug; ():. PubMed ID: 34446385
    [No Abstract]   [Full Text] [Related]  

  • 6. A false-positive case on brain
    Garcia JR; Baquero M; Bassa P; Compte A; Mourelo S; Riera E
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021 Apr; ():. PubMed ID: 33858799
    [No Abstract]   [Full Text] [Related]  

  • 7. Choline metabolism and its implications in cancer.
    Yao N; Li W; Xu G; Duan N; Yu G; Qu J
    Front Oncol; 2023; 13():1234887. PubMed ID: 38023163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET/MRI in prostate cancer: a systematic review and meta-analysis.
    Evangelista L; Zattoni F; Cassarino G; Artioli P; Cecchin D; Dal Moro F; Zucchetta P
    Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):859-873. PubMed ID: 32901351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
    Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
    Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET with (18)F-labelled choline-based tracers for tumour imaging: a review of the literature.
    Mertens K; Slaets D; Lambert B; Acou M; De Vos F; Goethals I
    Eur J Nucl Med Mol Imaging; 2010 Nov; 37(11):2188-93. PubMed ID: 20544193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choline-based imaging of prostate cancer with combined [
    Wetter A; Grüneisen J; Fliessbach K; Lütje S; Schaarschmidt B; Umutlu L
    Clin Imaging; 2017; 42():198-202. PubMed ID: 28110202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy.
    Yamaguchi T; Lee J; Uemura H; Sasaki T; Takahashi N; Oka T; Shizukuishi K; Endou H; Kubota Y; Inoue T
    Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):742-8. PubMed ID: 16052370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT.
    Testa C; Schiavina R; Lodi R; Salizzoni E; Corti B; Farsad M; Kurhanewicz J; Manferrari F; Brunocilla E; Tonon C; Monetti N; Castellucci P; Fanti S; Coe M; Grigioni WF; Martorana G; Canini R; Barbiroli B
    Radiology; 2007 Sep; 244(3):797-806. PubMed ID: 17652190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of MRI-assisted metabolic volumetric parameters provided by simultaneous (18)F-fluorocholine PET/MRI for primary prostate cancer characterization.
    Kim YI; Cheon GJ; Paeng JC; Cho JY; Kwak C; Kang KW; Chung JK; Kim EE; Lee DS
    Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1247-56. PubMed ID: 25759164
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.